Ten years of iron chelation in a patient with superficial siderosis.
作者信息
Levy Michael
机构信息
Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 15 Parkman St., Boston, MA, 02114, USA.
出版信息
Neurol Sci. 2019 Sep;40(9):1947-1949. doi: 10.1007/s10072-019-03791-w. Epub 2019 Mar 4.
Abstract
摘要
相似文献
1
Ten years of iron chelation in a patient with superficial siderosis.一名患有浅表性铁沉积症患者的十年铁螯合治疗历程。
Neurol Sci. 2019 Sep;40(9):1947-1949. doi: 10.1007/s10072-019-03791-w. Epub 2019 Mar 4.
2
Two-year observational study of deferiprone in superficial siderosis.两年观察性研究 deferiprone 在外周浅铁沉着症中的应用。
CNS Neurosci Ther. 2018 Mar;24(3):187-192. doi: 10.1111/cns.12792. Epub 2017 Dec 28.
3
Deferiprone Reduces Hemosiderin Deposition in Superficial Siderosis.去铁酮可减少浅表性铁沉积症中的含铁血黄素沉积。
Can J Neurol Sci. 2017 Mar;44(2):219-220. doi: 10.1017/cjn.2016.329. Epub 2016 Oct 28.
4
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis.与小脑幕下表浅铁沉积症治疗中使用口服去铁酮相关的风险。
J Neurol. 2020 Jan;267(1):239-243. doi: 10.1007/s00415-019-09577-6. Epub 2019 Oct 16.
5
Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator.铁螯合剂治疗术后并发脑表面铁沉积患者的临床和影像学定量恢复。
J Neurol. 2022 May;269(5):2539-2548. doi: 10.1007/s00415-021-10844-8. Epub 2021 Oct 18.
6
Deferiprone ameliorates memory impairment in Scopolamine-treated rats: The impact of its iron-chelating effect on β-amyloid disposition.地拉罗司改善东莨菪碱处理大鼠的记忆障碍：其螯合铁效应对β-淀粉样蛋白分布的影响。
Behav Brain Res. 2020 Jan 27;378:112314. doi: 10.1016/j.bbr.2019.112314. Epub 2019 Oct 20.
7
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation.去铁酮治疗脑铁蓄积性神经退行性变的初步试验。
Haematologica. 2011 Nov;96(11):1708-11. doi: 10.3324/haematol.2011.043018. Epub 2011 Jul 26.
8
Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.针对帕金森病和肌萎缩侧索硬化等神经退行性疾病的保守铁螯合治疗。
J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7.
9
Treatment of superficial siderosis with iron chelation therapy.用铁螯合疗法治疗浅表性铁沉着症。
BMJ Case Rep. 2013 Jul 9;2013:bcr2013009916. doi: 10.1136/bcr-2013-009916.
10
Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.去铁酮与去铁胺联合治疗对快速清除地中海贫血患者体内过量心脏铁及预防心脏病的有效性。国际口服螯合剂委员会方案。
Hemoglobin. 2006;30(2):239-49. doi: 10.1080/03630260600642567.
引用本文的文献
1
Treatment Response of Deferiprone in Infratentorial Superficial Siderosis: a Systematic Review.脑桥小脑角浅表铁沉积症患者使用去铁酮的治疗反应：系统评价。
Cerebellum. 2021 Jun;20(3):454-461. doi: 10.1007/s12311-020-01222-7. Epub 2021 Jan 6.
2
Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.罕见神经系统疾病与神经科学：2020年罕见病日纪念报告
Neurol Sci. 2020 Mar;41(3):491-495. doi: 10.1007/s10072-020-04287-8.
本文引用的文献
1
Two-year observational study of deferiprone in superficial siderosis.两年观察性研究 deferiprone 在外周浅铁沉着症中的应用。
CNS Neurosci Ther. 2018 Mar;24(3):187-192. doi: 10.1111/cns.12792. Epub 2017 Dec 28.
2
Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway.桥小脑角区外表面铁沉积症：分类、诊断标准和合理的检查路径。
Ann Neurol. 2017 Mar;81(3):333-343. doi: 10.1002/ana.24850. Epub 2017 Jan 28.
3
Pilot safety trial of deferiprone in 10 subjects with superficial siderosis.10 例蛛网膜下腔铁沉积症患者中去铁酮的飞行员安全性试验。
Stroke. 2012 Jan;43(1):120-4. doi: 10.1161/STROKEAHA.111.628032. Epub 2011 Oct 27.
4
Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis.地拉罗司减少了一位脑部铁蛋白沉积症患者脑内的含铁血黄素沉积。
AJNR Am J Neuroradiol. 2011 Jan;32(1):E1-2. doi: 10.3174/ajnr.A2331. Epub 2010 Nov 4.
5
Superficial siderosis: a case report and review of the literature.浅表性铁沉积症：一例病例报告及文献综述
Nat Clin Pract Neurol. 2007 Jan;3(1):54-8; quiz 59. doi: 10.1038/ncpneuro0356.
Zotero 插件